Cancer treatment—radiotherapy target site for lung cancer, code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
|---|---|
| Short name: | Radiotherapy target site (lung cancer) |
| Synonymous names: | Radiation therapy site |
| METEOR identifier: | 433274 |
| Registration status: | Health, Standard 08/05/2014 |
| Definition: | The target site of radiotherapy administered during the course of treatment for lung cancer, as represented by a code. |
| Data Element Concept: | Cancer treatment—radiotherapy target site |
| Value Domain: | Radiotherapy target site for lung cancer code N |
Value domain attributes | ||
Representational attributes | ||
| Representation class: | Code | |
|---|---|---|
| Data type: | Number | |
| Format: | N | |
| Maximum character length: | 1 | |
| Value | Meaning | |
| Permissible values: | 1 | Thoracic site |
| 2 | Non-thoracic site | |
| 3 | Thoracic and non-thoracic sites | |
| Supplementary values: | 7 | Not applicable-radiotherapy was not administered |
| 8 | Unknown whether radiotherapy was administered | |
| 9 | Radiotherapy was administered but the site not stated/inadequately described | |
Collection and usage attributes | |
| Guide for use: | More than one site may be targeted for radiotherapy. Record the appropriate code describing the site(s) that was the target of radiotherapy treatment administered for lung cancer. |
|---|---|
Source and reference attributes | |
| Submitting organisation: | Cancer Australia |
|---|---|
Data element attributes | |
Collection and usage attributes | |
| Guide for use: | Record the appropriate code describing the target site of radiotherapy administered for lung cancer. The target site for radiotherapy is recorded regardless of whether the course of treatment is completed as intended, the intent or timing of the radiotherapy, and the radiation treatment modality. Radiotherapy may be administered to both a thoracic and non-thoracic site. For example, a patient with lung cancer may receive radical radiotherapy to the primary site +/- regional nodes followed by prophylactic cranial irradiation or whole brain irradiation. |
|---|---|
| Collection methods: | This information should be obtained from the patient's radiotherapy records or from the radiation oncologist's summary letter. Determining the target site of radiotherapy may require assistance from the radiation oncologist for consistent coding. |
| Comments: | This is collected to identify which sites are targeted by radiotherapy and is useful in evaluating patterns of care and patient outcomes on a regional or national basis. |
Source and reference attributes | |
| Submitting organisation: | Cancer Australia |
| Reference documents: | American College of Surgeons 2002. Facility Oncology Registry Data Standards (FORDS), 2011 revision. Commission on Cancer |
Relational attributes | |
| Related metadata references: | See also Cancer treatment—radiation dose administered, total Gray N[NN.NN] Health, Standard 08/05/2014 See also Cancer treatment—radiotherapy completion date, DDMMYYYY Health, Standard 08/05/2014 See also Cancer treatment—radiotherapy fractions administered, total fractions N[N] Health, Standard 08/05/2014 |
| Implementation in Data Set Specifications: | |